Nerve growth factor is an autocrine survival factor for memory B lymphocytes

Cell

Volumn 85, Issue 3, 1996, Pages 345-356

  Torcia, Maria ^a,b   Bracci Laudiero, Luisa ^c   Lucibello, Maria ^a   Nencioni, Lucia ^a   Labardi, Danilo ^a   Rubartelli, Anna ^d   Cozzolino, Federico ^a   Aloe, Luigi ^c   Garaci, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL SURVIVAL; ETIOLOGY; HUMAN; HUMAN CELL; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029898913     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81113-7     Document Type: Article

References (62)

1. Aloe, L., Skaper, S.D., Leon, A., and Levi-Montalcini, R. (1994). Nerve growth factor and autoimmune diseases. Autoimmunity 19, 141-150.
2. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Roberts, R.L., Noell, R.J., Ledbetter, J.A., Francke, U., and Ochs, H.D. (1993). The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300.
3. Barbacid, M. (1994). The Trk family of neurotrophin receptors. J. Neurobiol. 25, 386-403.
4. Barde, Y.A. (1990). The nerve growth factor family. Prog. Growth Factor Res. 2, 237-248.
5. Batistatou, A., Merry, D.E., Korsmeyer, S.J., and Greene, L.A. (1993). Bcl-2 affects survival but not neuronal differentiation of PC12 cells. J. Neurosci. 13, 4422-4428.
6. Benedetti, M., Levi, A., and Chao, M.V. (1993). Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Natl. Acad. Sci. USA 90, 7859-7863.
7. Bracci-Laudiero, L., Aloe, L., Levi-Montalcini, R., Galeazzi, M., Schilter, D., Scully, J.L., and Otten, U. (1993). Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 4, 563-565.
8. Brodie, C., and Gelfand, E.W. (1992). Functional nerve growth factor receptors on human B lymphocytes: interaction with IL-2. J. Immunol. 148, 3492-3497.
9. Brunner, T., Mogil, R.J., LaFace, D., Yoo, N.J., Mahboubi, A., Echeverri, F., Martin, S.J., Force, W.R., Lynch, D.H., Ware, C.F., and Green, D.R. (1995). Cell-autonomous Fas (CD95)-Fas ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373, 441-444.
10. Burton, K. (1956). A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62, 315-323.
11. Chao, M.V. (1994). The p75 neurotrophin receptor. J. Neurobiol. 25, 1373-1385.
12. Cohen, S. (1960). Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc. Natl. Acad. Sci. USA 46, 302-311.
13. Cozzolino, F., Rubartelli, A., Aldinucci, D., Sitia, R., Torcia, M., Shaw, A., and Di Guglielmo, R. (1989). Interleukin-1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 86, 2369-2373.
14. Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D., and Stern, D.M. (1990). Interleukin-1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA 87, 6487-6491.
15. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., and Krammer, P. (1995). Autocrine T cell suicide mediated by Apo-1-(Fas-CD95). Nature 373, 438-441.
16. Di Marco, E., Mathor, M., Bondanza, S., Cutuli, N., Marchisio, P.C., Cancedda, R., and De Luca, M. (1993). Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J. Biol. Chem. 268, 22838-22846.
17. Dicou, E., Masson, C., Jabbour, W., and Nerriere, V. (1993). Increased frequency of NGF in sera of rheumathoid arthritis and systemic lupus erythematosus patients. Neuroreport 5, 321-324.
18. Eager, K.B. (1991). Molecular characterization of human Trk protooncogene product monoclonal antibodies. Oncogene 6, 819-824.
19. Ehrhard, P.B., Gauter, U., Stalder, A., Bauer, J., and Otten, U. (1993a). Expression of functional trk proto-oncogene in human monocytes. Proc. Natl. Acad. Sci. USA 90, 5423-5427.
20. Ehrhard, P.B., Erb, P., Graumann, U., and Otten, U. (1993b). Expression of nerve growth factor and nerve growth factor tyrosine kinase Trk in activated CD4-positive T cell clones. Proc. Natl. Acad. Sci. USA 90, 10981-10984.
21. Ernfors, P., Wetmore, C., Olson, L., and Persson, H. (1990). Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5, 511-526.
22. Fanslow, W.C., Anderson, D.M., Grabstein, K.H., Clark, E.A., Cosman, D., and Armitage, R.J. (1992). Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149, 655-660.
23. Gray, D. (1993). Immunological memory. Annu. Rev. Immunol. 11, 49-77.
24. Greenlund, L.J., Deckwerth, T.L., and Johnson, E.M., Jr. (1995). Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
25. Hawkins, C.J., and Vaux, D.L. (1994). Analysis of the role of Bcl-2 in apoptosis. Immunol. Rev. 142, 127-137.
26. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
27. Hofer, M., Pagliusi, S.R., Hohn, A., Leibrock, J., and Barde, Y.A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9, 2459-2464.
28. Huber, L.J., and Chao, M.V. (1995). A potential interaction of p75 and trk-ANGF receptors revealed by affinity cross-linking and immunoprecipitation. J. Neurosci. 40, 557-563.
29. 2. J. Clin. Invest. 89, 794-802.
30. Janet, T., Ludecke, G., Otten, U., and Unsicker, K. (1995). Heterogeneity of human cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors. J. Neurosci. Res. 40, 707-715.
31. Jing, S., Tapley, P., and Barbacid, M. (1992). Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9, 1067-1069.
32. Johnson, E.M., Rich, K.M., and Yp, H.K. (1986). The role of NGF in sensory neurons in vivo. Trends Neurosci. 9, 33-37.
33. Ju, S.-T., Panka, D.J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak-Rothstein, A. (1995). Fas(CD95)-FasL interactions required for programmed cell death after T cell activation. Nature 373, 444-448.
34. Katayama, N., Clark, S.C., and Ogawa, M. (1993). Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81, 610-616.
35. Kimata, H., Yoshida, A., Ishioka, C., Kusunoki, T., Hosoi, S., and Mikawa, H. (1991). Nerve growth factor specifically induces human IgG4 production. Eur. J. Immunol. 21, 137-141.
36. Kishimoto, T., and Hirano, T. (1989). B lymphocyte activation, proliferation, and immunoglobulin secretion. In Fundamental Immunology, Second Edition, W.E. Paul, ed. (New York: Raven Press, Limited), pp. 385-411.
37. Korsmeyer, S.J. (1992). Bcl-2: a repressor of lymphocyte death. Immunol. Today 13, 285-288.
38. Levi-Montalcini, R. (1987). The nerve growth factor: thirty-five years later. Science 237, 1154-1162.
39. Levi-Montalcini, R., and Angeletti, P.V. (1966). Immunosympathectomy. Pharmacol. Rev. 18, 619-628.
40. Levi-Montalcini, R., and Angeletti, P.V. (1968). Nerve growth factor. Physiol. Rev. 48, 534-569.
41. MacLennan, I.C., and Gray, D. (1986). Antigen-driven selection of virgin and memory B cells, Immunol. Rev. 91, 61-85.
42. Mannick, J.B., Asano, K., Kieff, E., and Stamler, J.S. (1994). Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79, 1137-1146.
43. McConkey, D.J., Hatzell, P., Nicotera, P., and Orrenius, S. (1989). Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3, 1844-1849.
44. Meakin, S.O., and Shooter, E.M. (1992). The nerve growth factor family of receptors. Trends Neurosci. 15, 323-331.
45. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP-1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
46. Nisonoff, A. (1967). Coupling of diazonium compounds to proteins. In Methods in Immunology and Immunochemistry, C.A. Williams and M.V. Chase, eds. (New York: Academic Press, Incorporated) pp. 1-20.
47. Nunez, G., Hockenbery, D., McDonnell, T.J., Sorensen, C.M., and Korsmeyer, S.J. (1991). Bcl-2 maintains B cell memory. Nature 353, 71-73.
48. Otten, U., Ehrhard, P., and Peck, R. (1989). Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA 86, 10059-10063.
49. Rabizadeh, S., Oh, J., Zhong, L.T., Young, J., Bitler, C.M., Butcher, L.L., and Bredesen, D.E. (1993). Induction of apoptosis by the low affinity NGF receptor. Science 261, 345-348.
50. Raffioni, S., Bradshaw, R.A., and Buxser, S.E. (1993). The receptors for nerve growth factor and other neurotrophins. Annu. Rev. Biochem. 62, 823-850.
51. Reth, M., Hammerling, G.J. and Rajewsky, K. (1978). Analysis of the repertoire of anti-NIP antibodies in C57BL/6 mice by cell fusion: characterization of antibody families in the primary and hyperimmune response. Eur. J. Immunol. 8, 393-400.
52. Romagnani, S., Giudizi, M.G., del Prete, G., Maggi, E., Biagiotti, R., Almerigogna, F., and Ricci, M. (1982). Demonstration on protein A of two distinct immunoglobulin-binding sites and their role in the mitogenic activity of Staphylococcus aureus Cowan I on human B cells. J. Immunol. 129, 596-602.
53. Santambrogio, L., Benedetti, M., Chao, M.V., Muzaffar, R., Kulig, K., Gabellini, N., and Hochwald, G. (1994). Nerve growth factor production by lymphocytes. J. Immunol. 153, 4488-4495.
54. Schittek, B., and Rajewsky, K. (1990). Maintenance of B cell memory by long-lived cells generated from proliferating precursors. Nature 346, 749-751.
55. Shelton, D.L., and Reichardt, L.F. (1986). Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggests that NGF functions as a trophic factor for several distinct populations of neurons. Proc. Natl. Acad. Sci. USA 83, 2714-2718.
56. Siekevitz, M., Kocks, C., Rajewsky, K., and Dildrop, R. (1987). Analysis of somatic mutation and class switching in native and memory B cells generating adoptive primary and secondary responses. Cell 48, 757-770.
57. Söderström, S., Hallböök, F., Ibàñez, C.F., Persson, H., and Ebendal, T. (1990). Recombinant human-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. J. Neurosci. Res. 27, 665-677.
58. Sprent, J. (1994). T and B memory cells. Cell 76, 315-322.
59. Ueyama, T., Hamada, M., Hano, T., Nishio, I., Masuyama, Y., and Furukawa, S. (1993). Production of nerve growth factor by cultured vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. J. Hypertens. 11, 1061-1065.
60. Wysocki, L.J., and Sato, V.L. (1978). "Panning" for lymphocytes: a method for cell separation. Proc. Natl. Acad. Sci. USA 75, 2840-2848.
61. Yaar, M., Eller, M.S., Di Benedetto, P., Reenstra, W.R., Zhai, S., McQuaid, T., Archambault, M., and Gilchrest, B.A. (1994). The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J. Clin. Invest. 94, 1550-1562.
62. Yao, R., and Cooper, G.M. (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.